Detalles de la búsqueda
1.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883228
2.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968460
3.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485994
4.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870453
5.
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Exp Parasitol
; 221: 108059, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338468
6.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitol Res
; 120(12): 4037-4047, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664113
7.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191446
8.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32772379
9.
Protein signatures that promote operator selectivity among paralog MerR monovalent metal ion regulators.
J Biol Chem
; 288(28): 20510-9, 2013 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23733186
10.
Mechanisms of SARS-CoV-2 Inactivation Using UVC Laser Radiation.
ACS Photonics
; 11(1): 42-52, 2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249683
11.
Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana.
Mol Diagn Ther
; 27(5): 583-592, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37462793
12.
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
ACS Cent Sci
; 8(5): 527-545, 2022 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35647275
13.
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
NPJ Vaccines
; 5: 75, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32821440
14.
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
Vaccines (Basel)
; 8(2)2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32526867
15.
Resultados
1 -
15
de 15
1
Próxima >
>>